"We have some concerns about the project with regard to the product manufacturing, clinical study enrollment pace, costs, and contractor performance."
Should Biota take pride in the above statement?
"we are considering what is the best next step for the Biota project and the overall influenza antiviral drug development program before going forward with clinical studies in the Southern Hemisphere and manufacturing optimization and validation."
Sorta implies the Phase 2 trial might re-start? Which means Russell's statement the other night about finalising and releasing top line data might not happen just yet.
- Forums
- ASX - By Stock
- BTA
- update from barda
update from barda, page-12
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online